1
|
Nakashima M, Toh N, Miki T, Takaya Y, Nakagawa K, Omori K, Miyoshi T, Nakamura K, Morita H, Akagi T, Yuasa S. Pathophysiology and management of adults with complex congenital heart disease after biventricular repair. J Cardiol 2025:S0914-5087(25)00085-1. [PMID: 40120854 DOI: 10.1016/j.jjcc.2025.03.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/14/2025] [Revised: 02/28/2025] [Accepted: 03/06/2025] [Indexed: 03/25/2025]
Abstract
Surgical management of congenital heart disease encompasses a spectrum of procedures, ranging from biventricular repair to univentricular palliation, each tailored to the specific anatomical and hemodynamic features of individual cases. Among these, biventricular repair, which preserves a functional ventricle to sustain pulmonary circulation, is prioritized whenever feasible. Advances in approaches have significantly improved outcomes, enabling many patients with congenital heart disease to reach adulthood, including the majority who have undergone biventricular repair. Despite these advancements, long-term complications-such as valvular disease, arrhythmias, heart failure, outflow tract obstruction, and dysfunction of extracardiac conduits-pose persistent challenges in the lifelong care of these patients. This review examines the distinct challenges and management strategies associated with adult patients who have undergone biventricular repair for complex congenital heart disease. The discussion focuses on key conditions, including repaired tetralogy of Fallot, transposition of the great arteries following atrial or arterial switch procedures, surgically managed or untreated congenitally corrected transposition of the great arteries with significant tricuspid regurgitation necessitating intervention, pulmonary atresia with intact ventricular septum, and Ebstein's anomaly. By addressing the long-term complications and therapeutic considerations unique to this patient population, this review aims to provide a comprehensive framework for optimizing care as these individuals transition into adulthood.
Collapse
Affiliation(s)
- Mitsutaka Nakashima
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
| | - Norihisa Toh
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
| | - Takashi Miki
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Yoichi Takaya
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Koji Nakagawa
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Kazuhiro Omori
- Department of Pathophysiology-Periodontal Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Toru Miyoshi
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Kazufumi Nakamura
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Hiroshi Morita
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Teiji Akagi
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Shinsuke Yuasa
- Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| |
Collapse
|
2
|
Moore JP, Waldmann V, Bessière F, Babouri N, Cohen MI, O'Leary ET, Patel NS, Nazer B, Tan W, Fish FA, Dalal AS, Mariucci E, Tan RB, Lloyd MS, McLeod CJ, Anderson CC, Kanter RJ, Johnson BV, Wang B, Chang PM, Newlon CA, Su J, Shannon KM, Bradfield JS, Shivkumar K, Aboulhosn JA, Khairy P. Age-Related Ventricular Tachycardia Substrate Characteristics for Repaired Tetralogy of Fallot Before Transcatheter Pulmonary Valve Placement. JACC Clin Electrophysiol 2025; 11:551-562. [PMID: 39818670 DOI: 10.1016/j.jacep.2024.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2024] [Revised: 11/08/2024] [Accepted: 11/11/2024] [Indexed: 01/18/2025]
Abstract
BACKGROUND Ventricular tachycardia (VT) substrate characteristics before transcatheter pulmonary valve replacement (TPVR) in repaired tetralogy of Fallot (rTOF) are unknown. OBJECTIVES In this study, the authors sought to evaluate substrates for sustained monomorphic VT before TPVR in rTOF. METHODS Retrospective (2017 to 2021) and prospective (commencing 2021) rTOF patients with native right ventricular outflow tract referred for electrophysiology study (EPS) before TPVR were included. Electrophysiologic findings and outcomes of VT ablation were determined. RESULTS A total of 180 patients (mean age 39 ± 14 years, 54% male, 71 retrospective, 109 prospective) were identified. At EPS, monomorphic VT was induced in 45 (25%), and a slowly conducting anatomic isthmus alone was observed in 40 (22%). VT isthmus conduction velocity decreased (-0.08 m/s per decade; P = 0.008) and VT inducibility (P < 0.001 for trend) and cycle length (CL) (+15 ms per decade, P = 0.005) increased with age. Multivariable factors associated with shorter VT CL included preserved isthmus conduction velocity (-50 ms per m/s; P = 0.02), absence of atrial flutter (-18 ms; P = 0.007), and improved RV ejection fraction (-16 ms per 10% increase; P = 0.007). Catheter ablation was acutely successful in 80/83 (96%). At repeated EPS after a median of 5 months, previously ablated substrates were evident in 3/24 (13%) and new VT substrates in 3/33 (9%). CONCLUSIONS Pre-TPVR VT substrates in rTOF demonstrate age-related degeneration that was associated with VT inducibility and VT CL. Both recovery of VT isthmus conduction and new VT substrates were observed after TPVR despite successful catheter ablation.
Collapse
Affiliation(s)
- Jeremy P Moore
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, UCLA Health System, Los Angeles, California, USA; Ahmanson/UCLA Adult Congenital Heart Disease Center, Division of Cardiology, Department of Medicine, Los Angeles, California, USA; Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA.
| | - Victor Waldmann
- Université Paris Cité, Inserm, PARCC, Paris, France; Adult Congenital Heart Disease Medico-Surgical Unit, European Georges Pompidou Hospital, Paris, France; M3C-Necker, Hôpital Universitaire Necker-Enfants Malades, APHP, Paris, France
| | - Francis Bessière
- Cardiac Electrophysiology Unit, European Georges Pompidou Hospital, Paris, France; Louis Pradel Hospital, Hospices Civils de Lyon, Université Lyon 1 Claude Bernard, Lyon, France
| | - Nawel Babouri
- Cardiac Electrophysiology Unit, European Georges Pompidou Hospital, Paris, France; Louis Pradel Hospital, Hospices Civils de Lyon, Université Lyon 1 Claude Bernard, Lyon, France
| | - Mitchell I Cohen
- Division of Cardiology, Inova Children's Hospital, Falls Church, Virginia, USA
| | - Edward T O'Leary
- Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Nimesh S Patel
- University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Babak Nazer
- Division of Cardiology, University of Washington, Seattle, Washington, USA
| | - Weiyi Tan
- University of Texas Southwestern Medical Center, Dallas, Texas, USA
| | - Frank A Fish
- Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA
| | - Aarti S Dalal
- Division of Pediatric Cardiology, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA
| | - Elisabetta Mariucci
- Pediatric Cardiology and Adult Congenital Heart Disease Program, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
| | - Reina B Tan
- Division of Pediatric Cardiology, NYU Langone School of Medicine, New York, New York, USA
| | - Michael S Lloyd
- Department of Cardiac Electrophysiology, Emory University, Atlanta, Georgia, USA
| | - Christopher J McLeod
- Department of Cardiovascular Diseases, Mayo Clinic Florida, Jacksonville, Florida, USA
| | - Charles C Anderson
- Providence Center for Congenital Heart Disease, Spokane, Washington, USA
| | - Ronald J Kanter
- Nicklaus Children's Hospital, Miami, Florida, USA; Duke University School of Medicine, Durham, North Carolina, USA
| | - Bryce V Johnson
- Division of Cardiology, University of Washington, Seattle, Washington, USA
| | - Bo Wang
- Department of Cardiac Electrophysiology, Emory University, Atlanta, Georgia, USA
| | | | - Claire A Newlon
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Jonathan Su
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Kevin M Shannon
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Jason S Bradfield
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, UCLA Health System, Los Angeles, California, USA
| | - Kalyanam Shivkumar
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, UCLA Health System, Los Angeles, California, USA
| | - Jamil A Aboulhosn
- Ahmanson/UCLA Adult Congenital Heart Disease Center, Division of Cardiology, Department of Medicine, Los Angeles, California, USA
| | - Paul Khairy
- Montreal Heart Institute, Montreal, Québec, Canada
| |
Collapse
|
3
|
Rojas SF, Nattel S, Hiram R, Khairy P. Right Ventricular Electrophysiology and Arrhythmias in Adults With Congenital Heart Disease: Scientific Basis for Management. Can J Cardiol 2025:S0828-282X(25)00103-5. [PMID: 39920991 DOI: 10.1016/j.cjca.2025.01.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2024] [Revised: 01/08/2025] [Accepted: 01/23/2025] [Indexed: 02/10/2025] Open
Abstract
Right ventricular (RV) dysfunction and arrhythmias are major concerns in adults with congenital heart disease (CHD). The relationship between RV dysfunction and arrhythmogenesis is bidirectional, with structural and electrical remodeling contributing to arrhythmia development and, conversely, arrhythmias exacerbating RV failure. In addition to an RV in the standard subpulmonary position failing because of pressure and/or volume overload, other phenotypes associated with RV dysfunction in CHD include transposition of the great arteries with a systemic (subaortic) RV and univentricular hearts with a predominant RV morphology. The RV is better suited for low-pressure workloads. When it supports the systemic circulation, the RV undergoes remodeling changes that promote arrhythmias, which can provoke a cycle of worsening dysfunction and arrhythmogenesis. Arrhythmias can worsen RV dysfunction by impairing hemodynamic stability, reducing cardiac output, provoking dyssynchrony, and inducing tachycardia-induced cardiomyopathy. Cellular mechanisms, including myocardial fibrosis, dysregulation of ion channels, and abnormal gap junction function, are central to this process, facilitating both re-entrant and triggered arrhythmias. Conduction disturbances, whether inherent or caused by fibrosis or pacing, compound these effects, aggravating both RV dysfunction and arrhythmia perpetuation. Management strategies must be comprehensive and include pre-emptive approaches to minimize arrhythmias, alongside early detection. Individualized therapies may include catheter ablation and cardiac implantable electronic devices, with treatment tailored to the specific RV phenotype and arrhythmia type. In this review we emphasize the importance of personalized interventions to prevent the vicious cycle of RV dysfunction and arrhythmias in CHD. Further research is essential to optimize therapeutic strategies and address care-limiting knowledge gaps.
Collapse
Affiliation(s)
| | - Stanley Nattel
- Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada
| | - Roddy Hiram
- Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada
| | - Paul Khairy
- Montréal Heart Institute, Université de Montréal, Montréal, Québec, Canada.
| |
Collapse
|
4
|
Czosek RJ, Baskar S, Connor CE. Emergence of SCAI in Patients With Tetralogy of Fallot: Early Ablation Target or Moving Target. JACC Clin Electrophysiol 2024; 10:2625-2627. [PMID: 39520432 DOI: 10.1016/j.jacep.2024.09.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2024] [Accepted: 09/01/2024] [Indexed: 11/16/2024]
Affiliation(s)
- Richard J Czosek
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati Medical Center, Cincinnati, Ohio, USA.
| | - Shankar Baskar
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA; University of Cincinnati Medical Center, Cincinnati, Ohio, USA
| | - Chad E Connor
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA
| |
Collapse
|
5
|
Moore JP. Prophylactic electrophysiologic interventions in congenital heart disease: New insights and fresh controversy. Heart Rhythm 2024:S1547-5271(24)03611-7. [PMID: 39579947 DOI: 10.1016/j.hrthm.2024.11.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2024] [Accepted: 11/14/2024] [Indexed: 11/25/2024]
Affiliation(s)
- Jeremy P Moore
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, Ahmanson/UCLA Adult Congenital Heart Disease Center, and Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California.
| |
Collapse
|
6
|
Johnson BV, Sonderman M, Magoon MJ, Pistner A, Hanna B, Bevan GH, McDonagh R, Boyle PM, Robinson MR, Akoum N, Chatterjee NA, Krieger EV, Nazer B. Slowly conducting anatomic isthmuses of tetralogy of Fallot: An opportunity for "prophylactic" ventricular tachycardia ablation. Heart Rhythm 2024:S1547-5271(24)03539-2. [PMID: 39561932 DOI: 10.1016/j.hrthm.2024.10.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/21/2024] [Revised: 10/23/2024] [Accepted: 10/30/2024] [Indexed: 11/21/2024]
Abstract
BACKGROUND Patients with repaired tetralogy of Fallot are at risk of ventricular tachycardia (VT) and sudden cardiac death. Most VTs arise from 5 slowly conducting anatomic isthmuses (SCAIs; conduction velocity ≤0.5 m/s) bound by the right ventriculotomy, ventricular septal defect patch, and tricuspid and pulmonic valves. Historically, risk stratification electrophysiologic studies involved programmed ventricular stimulation with VT induction guiding implantable cardioverter-defibrillator (ICD) implantation or VT ablation. OBJECTIVE This study aimed to evaluate a "prophylactic" strategy of ablating SCAIs even in the absence of inducible VT to reduce ICD implantation and arrhythmic events and to compare this with the "historical" strategy. METHODS This was a single-center, retrospective cohort study. The historical cohort underwent programmed ventricular stimulation to guide ICD implantation or VT ablation. The prophylactic cohort underwent right ventricular electroanatomic mapping and ablation of SCAIs. A composite end point of arrhythmic death, cardiac arrest, sustained VT, and ICD complication was compared between the cohorts. RESULTS Ninety-two patients with repaired tetralogy of Fallot had risk stratification electrophysiologic studies. Of 57 prophylactic patients, SCAIs were identified or ablated in 33 (58%), 16 (28%) had inducible VT before ablation, and 1 received ICD. Of 35 historical patients, 15 (43%) had inducible VT; 3 had cryoablation during pulmonic valve replacement and 11 received ICDs. No prophylactic patients met the composite end point during a median 21 months (interquartile range, 8-35 months) vs 10 (29%) historical patients during a median 125 months (interquartile range, 90-142 months; P = .017). There were no ablation-related complications. CONCLUSION Prophylactic SCAI ablation is associated with fewer ICD implantations and a reduction in incident arrhythmic events without ablation-related complications.
Collapse
Affiliation(s)
- Bryce V Johnson
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Mark Sonderman
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Matthew J Magoon
- Department of Bioengineering, University of Washington Medical Center, Seattle, Washington
| | - Andrew Pistner
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Bishoy Hanna
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Graham H Bevan
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | | | - Patrick M Boyle
- Department of Bioengineering, University of Washington Medical Center, Seattle, Washington
| | | | - Nazem Akoum
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Neal A Chatterjee
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Eric V Krieger
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington
| | - Babak Nazer
- Division of Cardiology, University of Washington Medical Center, Seattle, Washington.
| |
Collapse
|
7
|
Khairy P. A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot. Eur Heart J 2024; 45:2095-2097. [PMID: 38780021 DOI: 10.1093/eurheartj/ehae196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/25/2024] Open
Affiliation(s)
- Paul Khairy
- Electrophysiology Service and Adult Congenital Heart Disease Center, Montreal Heart Institute, Université de Montréal, 5000 Belanger St. E., Montreal H1T 1C8, Quebec, Canada
| |
Collapse
|
8
|
Kimura Y, Wallet J, Bouyer B, Jongbloed MRM, Bertels R, Hazekamp MG, Thambo JB, Iriart X, Cochet H, Sacher F, Lamb HJ, Blom NA, Zeppenfeld K. Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot. Eur Heart J 2024; 45:2079-2094. [PMID: 38748258 DOI: 10.1093/eurheartj/ehae268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Revised: 03/14/2024] [Accepted: 04/15/2024] [Indexed: 06/15/2024] Open
Abstract
BACKGROUND AND AIMS Patients with repaired tetralogy of Fallot remain at risk of life-threatening ventricular tachycardia related to slow-conducting anatomical isthmuses (SCAIs). Preventive ablation of SCAI identified by invasive electroanatomical mapping is increasingly performed. This study aimed to non-invasively identify SCAI using 3D late gadolinium enhancement cardiac magnetic resonance (3D-LGE-CMR). METHODS Consecutive tetralogy of Fallot patients who underwent right ventricular electroanatomical mapping (RV-EAM) and 3D-LGE-CMR were included. High signal intensity threshold for abnormal myocardium was determined based on direct comparison of bipolar voltages and signal intensity by co-registration of RV-EAM with 3D-LGE-CMR. The diagnostic performance of 3D-LGE-CMR to non-invasively identify SCAI was determined, validated in a second cohort, and compared with the discriminative ability of proposed risk scores. RESULTS The derivation cohort consisted of 48 (34 ± 16 years) and the validation cohort of 53 patients (36 ± 18 years). In the derivation cohort, 78 of 107 anatomical isthmuses (AIs) identified by EAM were normal-conducting AI, 22 were SCAI, and 7 blocked AI. High signal intensity threshold was 42% of the maximal signal intensity. The sensitivity and specificity of 3D-LGE-CMR for identifying SCAI or blocked AI were 100% and 90%, respectively. In the validation cohort, 85 of 124 AIs were normal-conducting AI, 36 were SCAI, and 3 blocked AI. The sensitivity and specificity of 3D-LGE-CMR were 95% and 91%, respectively. All risk scores showed an at best modest performance to identify SCAI (area under the curve ≤ .68). CONCLUSIONS 3D late gadolinium enhancement cardiac magnetic resonance can identify SCAI with excellent accuracy and may refine non-invasive risk stratification and patient selection for invasive EAM in tetralogy of Fallot.
Collapse
Affiliation(s)
- Yoshitaka Kimura
- Department of Cardiology, Heart-Lung-Center, Leiden University Medical Center (LUMC), P.O. Box 9600, Leiden 2300 RC, The Netherlands
- Willem Einthoven Center of Arrhythmia Research and Management (WECAM), Leiden, The Netherlands, and Aarhus, Denmark
| | - Justin Wallet
- Department of Cardiology, Heart-Lung-Center, Leiden University Medical Center (LUMC), P.O. Box 9600, Leiden 2300 RC, The Netherlands
- Willem Einthoven Center of Arrhythmia Research and Management (WECAM), Leiden, The Netherlands, and Aarhus, Denmark
| | - Benjamin Bouyer
- Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, Bordeaux University Hospital (CHU), Bordeaux, France
| | - Monique R M Jongbloed
- Department of Cardiology, Heart-Lung-Center, Leiden University Medical Center (LUMC), P.O. Box 9600, Leiden 2300 RC, The Netherlands
- Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL), Leiden, The Netherlands
- Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands
| | - Robin Bertels
- Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL), Leiden, The Netherlands
- Department of Pediatric Cardiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Mark G Hazekamp
- Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL), Leiden, The Netherlands
- Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands
| | - Jean-Benoit Thambo
- Department of Congenital Heart Disease, Bordeaux University Hospital, Bordeaux, France
| | - Xavier Iriart
- Department of Congenital Heart Disease, Bordeaux University Hospital, Bordeaux, France
| | - Hubert Cochet
- Department of Radiology, Bordeaux University Hospital, Bordeaux, France
| | - Frederic Sacher
- Department of Cardiac Pacing and Electrophysiology, IHU Liryc, Electrophysiology and Heart Modeling Institute, Bordeaux University Hospital (CHU), Bordeaux, France
| | - Hildo J Lamb
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Nico A Blom
- Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL), Leiden, The Netherlands
- Department of Pediatric Cardiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Katja Zeppenfeld
- Department of Cardiology, Heart-Lung-Center, Leiden University Medical Center (LUMC), P.O. Box 9600, Leiden 2300 RC, The Netherlands
- Willem Einthoven Center of Arrhythmia Research and Management (WECAM), Leiden, The Netherlands, and Aarhus, Denmark
| |
Collapse
|
9
|
Flores-Umanzor E, Alshehri B, Keshvara R, Wilson W, Osten M, Benson L, Abrahamyan L, Horlick E. Transcatheter-Based Interventions for Tetralogy of Fallot Across All Age Groups. JACC Cardiovasc Interv 2024; 17:1079-1090. [PMID: 38749587 DOI: 10.1016/j.jcin.2024.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/31/2024] [Accepted: 02/13/2024] [Indexed: 05/26/2024]
Abstract
Tetralogy of Fallot (TOF) is the most common form of cyanotic congenital heart disease. Palliative procedures, either surgical or transcatheter, aim to improve oxygen saturation, affording definitive procedures at a later stage. Transcatheter interventions have been used before and after surgical palliative or definitive repair in children and adults. This review aims to provide an overview of the different catheter-based interventions for TOF across all age groups, with an emphasis on palliative interventions, such as patent arterial duct stenting, right ventricular outflow tract stenting, or balloon pulmonary valvuloplasty in infants and children and transcatheter pulmonary valve replacement in adults with repaired TOF, including the available options for a large, dilated native right ventricular outflow tract.
Collapse
Affiliation(s)
- Eduardo Flores-Umanzor
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Cardiology Department, Cardiovascular Institute, Hospital ClĂnic, University of Barcelona, Barcelona, Spain
| | - Bandar Alshehri
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada
| | - Rajesh Keshvara
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada
| | - William Wilson
- Royal Melbourne Hospital Cardiology, Parkville, Victoria, Australia
| | - Mark Osten
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada
| | - Lee Benson
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; The Labatt Family Heart Centre, Division of Cardiology, The Hospital for Sick Children, The Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
| | - Lusine Abrahamyan
- Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada; Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada
| | - Eric Horlick
- Toronto Congenital Cardiac Centre for Adults, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
| |
Collapse
|
10
|
Moore JP, Su J, Shannon KM, Perens GS, Newlon C, Bradfield JS, Shivkumar K. Multidetector Computed Tomography Assessment of Anatomical Ventricular Tachycardia Isthmuses in Repaired Tetralogy of Fallot. JACC Clin Electrophysiol 2024; 10:857-866. [PMID: 38456860 DOI: 10.1016/j.jacep.2024.102333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2023] [Revised: 01/19/2024] [Accepted: 01/30/2024] [Indexed: 03/09/2024]
Abstract
BACKGROUND Tetralogy of Fallot (TOF) is associated with risk for sustained monomorphic ventricular tachycardia (VT). Preemptive electrophysiology study before transcatheter pulmonary valve placement is increasing, but the value of MDCT for anatomical VT isthmus assessment is unknown. OBJECTIVES The purpose of this study was to determine the impact of multidetector computed tomography (MDCT) in the evaluation of sustained monomorphic VT for repaired TOF. METHODS Consecutive pre-transcatheter pulmonary valve MDCT studies were identified, and anatomical isthmus dimensions were measured. For a subset of patients with preemptive electrophysiology study, MDCT features were compared with electroanatomical maps. RESULTS A total of 61 repaired TOFs with MDCT were identified (mean 35 ± 14 years, 58% men) with MDCT electroanatomical map pairs in 35 (57%). Calcification corresponding to patch material was present in 46 (75%) and was used to measure anatomical VT isthmuses. MDCT wall thickness correlated positively with number of ablation lesions and varied with functional isthmus properties (blocked isthmus 2.6 mm [Q1, Q3: 2.1, 4.0 mm], slow conduction 4.8 mm [Q1, Q3: 3.3, 6.0 mm], and normal conduction 5.6 mm [Q1, Q3: 3.9, 8.3 mm]; P < 0.001). A large conal branch was present in 6 (10%) and a major coronary anomaly was discovered in 3 (5%). Median ablation lesion distance was closer to the right vs the left coronary artery (10 mm vs 15 mm; P = 0.01) with lesion-to-coronary distance <5 mm in 3 patients. CONCLUSIONS MDCT identifies anatomical structures relevant to catheter ablation for repaired TOF. Wall thickness at commonly targeted anatomical VT isthmuses is associated with functional isthmus properties and increased thermal energy delivery.
Collapse
Affiliation(s)
- Jeremy P Moore
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, Los Angeles, California, USA; Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, California, USA; Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA.
| | - Jonathan Su
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Kevin M Shannon
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Gregory S Perens
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Claire Newlon
- Division of Pediatric Cardiology, Department of Pediatrics, David Geffen School of Medicine, UCLA Health System, Los Angeles, California, USA
| | - Jason S Bradfield
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, Los Angeles, California, USA
| | - Kalyanam Shivkumar
- University of California Los Angeles (UCLA) Cardiac Arrhythmia Center, Los Angeles, California, USA
| |
Collapse
|
11
|
Ramdat Misier NL, de Groot NMS. Multimodality Assessment of Anatomical Isthmuses in Tetralogy of Fallot: Check the Weather Before Setting Sail! JACC Clin Electrophysiol 2024; 10:867-869. [PMID: 38811069 DOI: 10.1016/j.jacep.2024.03.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Accepted: 03/09/2024] [Indexed: 05/31/2024]
Affiliation(s)
- Nawin L Ramdat Misier
- Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands
| | - Natasja M S de Groot
- Department of Cardiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
| |
Collapse
|
12
|
Vô C, Dib N, Bartoletti S, Gonzalez CM, Mondésert B, Gagnon MH, Fournier A, Khairy P. Navigating Arrhythmias in Tetralogy of Fallot Throughout the Lifespan: A Case-based Review. CJC PEDIATRIC AND CONGENITAL HEART DISEASE 2023; 2:404-413. [PMID: 38161682 PMCID: PMC10755829 DOI: 10.1016/j.cjcpc.2023.09.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Accepted: 09/12/2023] [Indexed: 01/03/2024]
Abstract
Arrhythmias are a common complication associated with tetralogy of Fallot (ToF), one of the most prevalent forms of congenital heart disease. As illustrated by this case-based review, various forms of arrhythmias can be encountered across the lifespan of patients with ToF, from infancy to older adulthood. These include atrioventricular block, junctional ectopic tachycardia, and atrial and ventricular arrhythmias. Arrhythmias have important implications on the health and quality of life of patients with ToF and require treatment by caregivers with dedicated expertise. The choice of pharmacologic and/or interventional therapies to alleviate symptoms, avoid complications, and mitigate risks depends in part on the type, severity, and frequency of the arrhythmia, as well as on the particularities of individual clinical scenarios. Preventing, monitoring for, and managing arrhythmias are an integral component of the care of patients with ToF throughout their lifespan that is critical to optimizing health outcomes.
Collapse
Affiliation(s)
- Christophe VĂ´
- Division of Pediatric Cardiology, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
- Electrophysiology Service, Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada
| | - Nabil Dib
- Division of Pediatric Cardiac Surgery, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
| | - Stefano Bartoletti
- Electrophysiology Service, Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada
| | - Cecilia M. Gonzalez
- Division of Pediatric Cardiology, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
| | - Blandine Mondésert
- Electrophysiology Service, Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada
| | - Marie-Hélène Gagnon
- Division of Pediatric Cardiology, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
| | - Anne Fournier
- Division of Pediatric Cardiology, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
| | - Paul Khairy
- Division of Pediatric Cardiology, Centre Hospitalier Universitaire Ste-Justine, Université de Montréal, Montreal, Québec, Canada
- Electrophysiology Service, Montreal Heart Institute, Université de Montréal, Montreal, Québec, Canada
| |
Collapse
|
13
|
Ramdat Misier NL, de Groot NMS. ECG, the old kid around the block who betrays conduction secrets in patients with tetralogy of Fallot. Heart Rhythm 2023; 20:1697-1698. [PMID: 37678494 DOI: 10.1016/j.hrthm.2023.08.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2023] [Accepted: 08/31/2023] [Indexed: 09/09/2023]
|
14
|
Crea F. Hot topics in congenital heart disease: tetralogy of Fallot, Ross operation, immunodeficiency, cardiac arrest, and end-stage heart failure. Eur Heart J 2023; 44:3201-3204. [PMID: 37673665 DOI: 10.1093/eurheartj/ehad549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/08/2023] Open
Affiliation(s)
- Filippo Crea
- Department of Cardiovascular Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
- Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy
| |
Collapse
|